ArticleBulletin of experimental biology and medicine2025
Immunomodulatory Activity of Lantibiotics Isolated from Growth Media of Coagulase-Negative Staphylococci In Vitro.
Article in Bulletin of experimental biology and medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Bacteriocins in Veterinary Medicine: From Antibiotic Limitations to Targeted Solutions.International journal of molecular sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lantibiotics warnerin and hominin isolated from growth media of Staphylococcus warneri DSMZ 16081 and S. hominis GISK 284, respectively, have pronounced immunomodulatory effects. Both peptides significantly modulated the microbicidal potential of leukocytes; the effect depended on the concentration and presence of the inducer. Warnerin inhibited ROS in high concentrations and stimulated ROS production in low concentrations in both spontaneous and stimulated samples. Hominin, on the contrary, enhanced spontaneous ROS production, but inhibited stimulated ROS production. Both peptides decreased the phagocytic activity of monocytes and neutrophils and activated the spontaneous production of both pro- (IL-1β, IL-6) and anti-inflammatory (IL-10) cytokines. Comparison of the two peptides revealed that hominin showed higher immunomodulatory activity.
Indexed as
Identifiers
41507486What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.